Choosing first line therapy for chronic lymphocytic leukemia

Por Jaglowski, Samantha, Jones, Jeffrey A.
Publicado no Expert Rev Anticancer Ther (2011)

Graft-versus-Host Disease: Why Haven’t We Made More Progress?

Por Jaglowski, Samantha M., Devine, Steven M.
Publicado em 2014

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia

Por Jaglowski, Samantha M., Alinari, Lapo, Lapalombella, Rosa, Muthusamy, Natarajan, Byrd, John C.
Publicado em 2010

Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices

Por Ardura, Monica, Hartley, David, Dandoy, Christopher, Lehmann, Leslie, Jaglowski, Samantha, Auletta, Jeffery J.
Publicado no Biol Blood Marrow Transplant (2020)

A phase 2 trial of alisertib in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Por Cohen, Jonathon B., Maddocks, Kami J., Huang, Ying, Christian, Beth A., Jaglowski, Samantha M., Flowers, Christopher R., Blum, Kristie A.
Publicado no Leuk Lymphoma (2017)

A new standard in GVHD prophylaxis? An introduction to BMT CTN 1703

Por DeFilipp, Zachariah, Burns, Linda J., Jaglowski, Samantha M., Leppin, Aaron L., Pavletic, Steven, Waldman, Bryce, Weisdorf, Daniel J., Wood, William A., Khera, Nandita
Publicado no Biol Blood Marrow Transplant (2020)

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

Por Guinn, Daphne, Ruppert, Amy S., Maddocks, Kami, Jaglowski, Samantha, Gordon, Amber, Lin, Thomas S., Larson, Richard, Marcucci, Guido, Hertlein, Erin, Woyach, Jennifer, Johnson, Amy J., Byrd, John C.
Publicado no Leukemia (2014)

A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

Por Haverkos, Bradley M., Huang, Ying, Elder, Patrick, O’Donnell, Lynn, Scholl, Diane, Whittaker, Becky, Vasu, Sumi, Penza, Sam, Andritsos, Leslie A., Devine, Steven M., Jaglowski, Samantha M.
Publicado no Bone Marrow Transplant (2017)

Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia

Por Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A.
Publicado em 2012

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

Por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado em 2014

Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem...

Por Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Publicado no Leuk Lymphoma (2014)

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Por Epperla, Narendranath, Ahn, Kwang Woo, Armand, Philippe, Jaglowski, Samantha, Ahmed, Sairah, Kenkre, Vaishalee P., Savani, Bipin, Jagasia, Madan, Shah, Nirav N., Fenske, Timothy S., Sureda, Ana, Smith, Sonali M., Hamadani, Mehdi
Publicado no Biol Blood Marrow Transplant (2017)

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

Por Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Publicado no Cancer Med (2017)

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765

Por Herman, Sarah E. M., Gordon, Amber L., Hertlein, Erin, Ramanunni, Asha, Zhang, Xiaoli, Jaglowski, Samantha, Flynn, Joseph, Jones, Jeffrey, Blum, Kristie A., Buggy, Joseph J., Hamdy, Ahmed, Johnson, Amy J., Byrd, John C.
Publicado em 2011

Dinaciclib is a Novel Cyclin Dependent Kinase Inhibitor with Significant Clinical Activity in Relapsed and Refractory Chronic Lymphocytic Leukemia

Por Flynn, Joseph, Jones, Jeffrey, Johnson, Amy J., Andritsos, Leslie, Maddocks, Kami, Jaglowski, Samantha, Hessler, Joshua, Grever, Michael R., Ellie, Im, Zhou, Honghong, Zhu, Yali, Zhang, Da, Small, Karen, Bannerji, Rajat, Byrd, John C.
Publicado no Leukemia (2015)

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

Por Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Publicado em 2014

Incidence and Description of Autoimmune Cytopenias During Treatment with Ibrutinib for Chronic Lymphocytic Leukemia Autoimmune Cytopenias During Ibrutinib Treatment

Por Rogers, Kerry A., Ruppert, Amy S., Bingman, Anissa, Andritsos, Leslie A., Awan, Farrukh T., Blum, Kristie A., Flynn, Joseph M., Jaglowski, Samantha M., Lozanski, Gerard, Maddocks, Kami J., Byrd, John C., Woyach, Jennifer A., Jones, Jeffrey A.
Publicado no Leukemia (2015)

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Por Maly, Joseph J., Christian, Beth A., Zhu, Xiaohua, Wei, Lai, Sexton, Jennifer L., Jaglowski, Samantha M., Devine, Steven M., Fehniger, Todd A., Wagner-Johnston, Nina D., Phelps, Mitch A., Bartlett, Nancy L., Blum, Kristie A.
Publicado no Clin Lymphoma Myeloma Leuk (2017)

Use of a Comprehensive Frailty Assessment to Predict Morbidity in Patients with Multiple Myeloma undergoing Transplant

Por Rosko, Ashley E., Huang, Ying, Benson, Don M., Efebera, Yvonne A., Hofmeister, Craig, Jaglowski, Samantha, Devine, Steven, Bhatt, Geetika, Wildes, Tanya M., Dyko, Alanna, Jones, Desirée, Naughton, Michelle J., Byrd, John C., Burd, Christin E.
Publicado no J Geriatr Oncol (2018)

Comparison of Fixed Dose Reduced-Intensity Conditioning with Fludarabine and Busulfan to PK-guided Busulfan AUC (FluBu4K) in Hematopoietic Stem Cell Transplant for AML/MDS

Por Rasor, Brendan, Dickerson, Tyler, Zhao, Qiuhong, Elder, Patrick, Brammer, Jonathan E, Larkin, Karilyn, Jaglowski, Samantha, Mims, Alice, Penza, Sam, Vasu, Sumithira, Wall, Sarah A, William, Basem, Saad, Ayman, Roddy, Julianna V.F., Choe, Hannah, Puto, Marcin
Publicado no Leuk Lymphoma (2020)